Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 232

1.

HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon.

Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, Haldar B, Powell RL, Jarido V, Hewlett IK, Nyambi PN.

J Med Virol. 2010 Feb;82(2):187-96. doi: 10.1002/jmv.21677.

PMID:
20029816
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
3.

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon.

Aghokeng AF, Kouanfack C, Eymard-Duvernay S, Butel C, Edoul GE, Laurent C, Koulla-Shiro S, Delaporte E, Mpoudi-Ngole E, Peeters M.

J Int AIDS Soc. 2013 Jan 31;16:18004. doi: 10.7448/IAS.16.1.18004.

PMID:
23374858
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria.

Santoro MM, Ciccozzi M, Alteri C, Montieri S, Alexiev I, Dimova I, Ceccherini-Silberstein F, Beshkov D, Rezza G, Perno CF.

AIDS Res Hum Retroviruses. 2008 Sep;24(9):1133-8. doi: 10.1089/aid.2008.0042.

PMID:
18788909
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.

Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.

Indian J Med Microbiol. 2009 Jul-Sep;27(3):231-6. doi: 10.4103/0255-0857.53205.

PMID:
19584504
[PubMed - indexed for MEDLINE]
Free Article
6.

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.

Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):242-9. doi: 10.1089/aid.2011.0300. Epub 2012 Aug 3.

PMID:
22860571
[PubMed - indexed for MEDLINE]
7.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

PMID:
19759509
[PubMed - indexed for MEDLINE]
Free Article
8.

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D.

JAMA. 2001 Jul 11;286(2):196-207.

PMID:
11448283
[PubMed - indexed for MEDLINE]
9.

Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.

Germanaud D, Derache A, Traore M, Madec Y, Toure S, Dicko F, Coulibaly H, Traore M, Sylla M, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2010 Jan;65(1):118-24. doi: 10.1093/jac/dkp412. Epub .

PMID:
19933171
[PubMed - indexed for MEDLINE]
Free Article
10.

Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.

Paolucci S, Baldanti F, Campanini G, Zavattoni M, Cattaneo E, Dossena L, Gerna G.

J Med Virol. 2001 Oct;65(2):207-17.

PMID:
11536225
[PubMed - indexed for MEDLINE]
11.

Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.

Ong LY, Razak SN, Lee YM, Sri La Sri Ponnampalavanar S, Syed Omar SF, Azwa RI, Tee KK, Kamarulzaman A.

J Med Virol. 2014 Jan;86(1):38-44. doi: 10.1002/jmv.23772. Epub 2013 Oct 11.

PMID:
24127302
[PubMed - indexed for MEDLINE]
12.

Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors.

Saracino A, Monno L, Scudeller L, Cibelli DC, Tartaglia A, Punzi G, Torti C, Lo Caputo S, Mazzotta F, Scotto G, Carosi G, Angarano G.

J Med Virol. 2006 Jan;78(1):9-17.

PMID:
16299731
[PubMed - indexed for MEDLINE]
13.

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Gottlieb GS, Badiane NM, Hawes SE, Fortes L, Toure M, Ndour CT, Starling AK, Traore F, Sall F, Wong KG, Cherne SL, Anderson DJ, Dye SA, Smith RA, Mullins JI, Kiviat NB, Sow PS; University of Washington-Dakar HIV-2 Study Group.

Clin Infect Dis. 2009 Feb 15;48(4):476-83. doi: 10.1086/596504. Erratum in: Clin Infect Dis. 2009 Mar 15;48(6):848.

PMID:
19143530
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.

Zolfo M, Schapiro JM, Phan V, Koole O, Thai S, Vekemans M, Fransen K, Lynen L.

AIDS Res Hum Retroviruses. 2011 Jul;27(7):727-35. doi: 10.1089/AID.2010.0037. Epub 2010 Nov 23.

PMID:
20854169
[PubMed - indexed for MEDLINE]
15.

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.

Gonsalez CR, Alcalde R, Nishiya A, Barreto CC, Silva FE, de Almeida A, Mendonça M, Ferreira F, Fernandes SS, Casseb J, Duarte AJ.

Virus Res. 2007 Nov;129(2):87-90. Epub 2007 Aug 7.

PMID:
17686543
[PubMed - indexed for MEDLINE]
16.

HIV type 1 virological response and prevalence of HIV type 1 drug resistance among patients receiving antiretroviral therapy, Shandong, China.

Zhang J, Kang D, Lin B, Sun X, Fu J, Bi Z, Nkengasong JN, Yang C.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1658-65. doi: 10.1089/AID.2012.0019. Epub 2012 Jun 11.

PMID:
22563717
[PubMed - indexed for MEDLINE]
17.

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E.

AIDS. 2003 Jul;17 Suppl 3:S31-8.

PMID:
14565607
[PubMed - indexed for MEDLINE]
18.

Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.

Arora SK, Gupta S, Toor JS, Singla A.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):125-30. doi: 10.1089/aid.2007.0156.

PMID:
18240959
[PubMed - indexed for MEDLINE]
19.

Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.

Bergroth T, Ekici H, Gisslén M, Loes SK, Goh LE, Freedman A, Lampe F, Johnson MA, Sönnerborg A.

J Med Virol. 2009 Jan;81(1):1-8. doi: 10.1002/jmv.21363.

PMID:
19031460
[PubMed - indexed for MEDLINE]
20.

Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.

Palacios-Saucedo GC, Rivera-Morales LG, Vázquez-Guillén JM, Sánchez LM, Ramírez TJ, Briones E, Ortiz-López R, Vázquez CA, Rodríguez-Padilla C.

Curr HIV Res. 2011 Apr;9(3):154-9.

PMID:
21457133
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk